Epidemiological and clinicopathological study of thyroid cancer in east Madrid

被引:3
作者
Carrera, CB
Torres, NP
García-Díaz, JD
Villaizan, EM
Sanz, JM
Hernández, JA
机构
[1] Univ Alcala de Henares, Hosp Principe Asturias, Secc Endocrinol, Madrid, Spain
[2] Univ Alcala de Henares, Hosp Principe Asturias, Secc Med Interna, Madrid, Spain
[3] Univ Alcala de Henares, Hosp Principe Asturias, Secc Anat Patol, Madrid, Spain
来源
REVISTA CLINICA ESPANOLA | 2005年 / 205卷 / 07期
关键词
thyroid neoplasm; incidence; risk factors; prognosis;
D O I
10.1157/13077115
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To analyze the incidence, clinical and histopathological manifestations, surgical complications, and prognostic factors of thyroid cancer in the east Madrid population. Patients and methods. Retrospective analysis of 141 consecutive diagnosed of thyroid cancer in our area between 1985 and 2001. Median follow-up was 4,5 years. Results. The annual incidence rate was 4.74/100,000 inhabitants and the female:male proportion 3.5:1. The average age of patients at diagnosis was 44.5 years and nodular goiter was the principal type of clinical presentation (74.5%). The most frequent histological variant was papillary thyroid carcinoma (69%). Total thyroidectomy was carried out in 86% patients. 9.6% patients suffered permanent hypoparathyroidism and 3.3% paralysis of recurrent laryngeal nerve. Radioactive iodine ablation of remaining thyroid was carried out in 91 patients. Residual disease or local recurrence was observed on follow-up in 21% of patients, and metastasis at a distant site in 9%. 7.9% died along follow-up. The principal prognostic factors for metastasis or death were age, histological type, tumor size, local invasion and existence of metastasis at the time of diagnosis. Conclusions. The incidence of thyroid cancer in our population was high, especially in women. Although the proportion of postsurgical complications was elevated, global prognosis is good and some factors related to it have been identified. Increase of thyroglobulin plasma level at follow-up is a good recurrence indicator of the disease, especially with regard to distant metastases.
引用
收藏
页码:307 / 310
页数:4
相关论文
共 29 条
[21]  
*NAT COMPR CANC NE, 2001, NCCN PRACT GUID THYR
[22]   SERUM THYROGLOBULIN IN THE FOLLOW-UP OF PATIENTS WITH TREATED DIFFERENTIATED THYROID-CANCER [J].
OZATA, M ;
SUZUKI, S ;
MIYAMOTO, T ;
LIU, RT ;
FIERRORENOY, F ;
DEGROOT, LJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (01) :98-105
[23]   DIAGNOSTIC-VALUE OF A SINGLE SERUM THYROGLOBULIN DETERMINATION ON AND OFF THYROID SUPPRESSIVE THERAPY IN THE FOLLOW-UP OF PATIENTS WITH DIFFERENTIATED THYROID-CANCER [J].
PACINI, F ;
LARI, R ;
MAZZEO, S ;
GRASSO, L ;
TADDEI, D ;
PINCHERA, A .
CLINICAL ENDOCRINOLOGY, 1985, 23 (04) :405-411
[24]   Medical progress - Papillary and follicular thyroid carcinoma [J].
Schlumberger, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (05) :297-306
[25]   Thyroid carcinoma [J].
Sherman, SI .
LANCET, 2003, 361 (9356) :501-511
[26]   First analysis of cancer incidence and occupational radiation exposure based on the National Dose Registry of Canada [J].
Sont, WN ;
Zielinski, JM ;
Ashmore, JP ;
Jiang, H ;
Krewski, D ;
Fair, ME ;
Band, PR ;
Létourneau, EG .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (04) :309-318
[27]   The importance of surgeon experience for clinical and economic outcomes from thyroidectomy [J].
Sosa, JA ;
Bowman, HM ;
Tielsch, JM ;
Powe, NR ;
Gordon, TA ;
Udelsman, R .
ANNALS OF SURGERY, 1998, 228 (03) :320-328
[28]  
Szybinski Z, 2001, Wiad Lek, V54 Suppl 1, P106
[29]   Optimal surgery for papillary thyroid carcinoma [J].
Udelsman, R ;
Lakatos, E ;
Ladenson, P .
WORLD JOURNAL OF SURGERY, 1996, 20 (01) :88-93